Fund shareholders of Sartorius Stedim Biotech
ISIN FR0013154002 · SIREN 314 093 352 · France · LEI 52990006IVXY7GCSSR39
- Fund shareholders
- 259
- Of which ETFs
- 62 197 other funds
- Value held
- 812.5M $ 198.9M SEK · 43M €
- Share of capital
- 4.4 % of 97.3M shares on Jul 1, 2026
- Sold short
- 1.7 % market aggregate, as of Aug 20, 2026
259 funds hold this company. This table lists the 242 that declare it in a regulatory filing. The other 17 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Länsförsäkringar Sparmål 2030 Länsförsäkringar Fondförvaltning AB | 135 | 246.3K SEK | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Multi-Managed International Equity Portfolio SEASONS SERIES TRUST | 130 | 25.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Pacer Trendpilot European Index ETF Pacer Funds Trust | 130 | 23.9K $ | 0.07 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Penn Series Developed International Index Fund Penn Series Funds Inc | 129 | 25.1K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Länsförsäkringar Sparmål 2065 Länsförsäkringar Fondförvaltning AB | 118 | 215.3K SEK | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Global Index Core Handelsbanken Fonder AB | 116 | 211.6K SEK | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Global Strategist Portfolio MORGAN STANLEY INSTITUTIONAL FUND TRUST | 112 | 21.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AZL MSCI Global Equity Index Fund Allianz Variable Insurance Products Trust | 104 | 20.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JNL/JPMorgan Global Allocation Fund JNL Series Trust | 103 | 20.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| E*TRADE No Fee International Index Fund E Trade Trust | 87 | 16.1K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Lord Abbett International Growth Fund LORD ABBETT TRUST I | 85 | 15.7K $ | 0.28 % | 0.00 % | as of Apr 30, 2026 ↗ |
| AZL DFA International Core Equity Fund Allianz Variable Insurance Products Trust | 82 | 16.1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares MSCI Kokusai ETF iShares Trust | 80 | 14.8K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) MSCI ACWI Climate Paris Aligned ETF SPDR INDEX SHARES FUNDS | 79 | 15.1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| GodFond Sverige & Världen Storebrand Asset Management AS | 78 | 142.3K SEK | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PGIM Quant Solutions International Developed Markets Index Fund Prudential Investment Portfolios 2 | 66 | 12.2K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| WisdomTree International Adaptive Moving Average Fund WisdomTree Trust | 62 | 11.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Länsförsäkringar Sparmål 2025 Länsförsäkringar Fondförvaltning AB | 55 | 100.3K SEK | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AB Dynamic Asset Allocation Portfolio AB VARIABLE PRODUCTS SERIES FUND, INC. | 53 | 10.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AMT Diversified Equity Fund ADVISER MANAGED TRUST | 53 | 9.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SPP Generation 40-tal Storebrand Asset Management AS | 49 | 89.4K SEK | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA JPMorgan Diversified Balanced Portfolio SUNAMERICA SERIES TRUST | 47 | 8.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| The ESG Growth Portfolio HC Capital Trust | 44 | 8.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Storebrand Europa Plus Storebrand Asset Management AS | 21 | 38.3K SEK | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| FlexShares STOXX Global ESG Select Index Fund FlexShares Trust | 20 | 3.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| M International Equity Fund M FUND INC | 19 | 3.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Global Strategist Portfolio MORGAN STANLEY VARIABLE INSURANCE FUND INC. | 16 | 3.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) MSCI World StrategicFactors(SM) ETF SPDR INDEX SHARES FUNDS | 11 | 2.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SPP Generation 50-tal Storebrand Asset Management AS | 8 | 14.6K SEK | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| CAIXABANK MULTISALUD, FI CAIXABANK ASSET MANAGEMENT SGIIC, S.A. | 32M € | 4.86 % | as of Dec 31, 2025 ↗ | ||
| SANTALUCIA QUALITY ACCIONES EUROPEAS, FI SANTA LUCIA ASSET MANAGEMENT, SGIIC, S.A. | 5M € | 3.42 % | as of Dec 31, 2025 ↗ | ||
| CAIXABANK GESTIÓN TENDENCIAS, FI CAIXABANK ASSET MANAGEMENT SGIIC, S.A. | 3M € | 1.70 % | as of Dec 31, 2025 ↗ | ||
| BESTINVER MEGATENDENCIAS, FI BESTINVER GESTION, S.A., S.G.I.I.C. | 948.8K € | 2.03 % | as of Dec 31, 2025 ↗ | ||
| ALBUS, FI CAIXABANK ASSET MANAGEMENT SGIIC, S.A. | 651K € | 0.28 % | as of Dec 31, 2025 ↗ | ||
| SANTALUCIA FONVALOR EURO, FI SANTA LUCIA ASSET MANAGEMENT, SGIIC, S.A. | 525K € | 1.51 % | as of Dec 31, 2025 ↗ | ||
| RENTA 4 NEXUS, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 477.8K € | 0.62 % | as of Dec 31, 2025 ↗ | ||
| BINDEX EUROPA INDICE, FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 177K € | 0.05 % | as of Dec 31, 2025 ↗ | ||
| CAIXABANK BOLSA GESTION EURO, FI CAIXABANK ASSET MANAGEMENT SGIIC, S.A. | 153.5K € | 0.15 % | as of Dec 31, 2025 ↗ | ||
| GESTION BOUTIQUE IV, FI GESTION BOUTIQUE IV/ONLY COMPOUNDERS ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 42K € | 2.63 % | as of Dec 31, 2025 ↗ | ||
| GESTION BOUTIQUE IV, FI GESTION BOUTIQUE IV/ASP OPPORTUNITIES FUND ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 27.7K € | 1.14 % | as of Dec 31, 2025 ↗ | ||
| GESTION BOUTIQUE II, FI GESTION BOUTIQUE II / ASPAIN 11 EQUILIBRADO ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 19.3K € | 0.71 % | as of Dec 31, 2025 ↗ | ||
| BINDEX EUROPA CTB INDICE, FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 4K € | 0.07 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Comgest Growth Europe Opportunities Comgest Asset Management International Limited | 5.56 % | as of Dec 31, 2025 ↗ |
| CAIXABANK MULTISALUD, FI CAIXABANK ASSET MANAGEMENT SGIIC, S.A. | 4.86 % | as of Dec 31, 2025 ↗ |
| Comgest Growth Europe Smaller Companies Comgest Asset Management International Limited | 4.67 % | as of Dec 31, 2025 ↗ |
| DNCA Invest - SRI Norden Europe DNCA Finance Luxembourg | 3.80 % | as of Dec 31, 2025 ↗ |
| SANTALUCIA QUALITY ACCIONES EUROPEAS, FI SANTA LUCIA ASSET MANAGEMENT, SGIIC, S.A. | 3.42 % | as of Dec 31, 2025 ↗ |
| Comgest Growth Europe S Comgest Asset Management International Limited | 3.32 % | as of Dec 31, 2025 ↗ |
| DNCA Invest - SRI Europe Growth DNCA Finance Luxembourg | 2.96 % | as of Dec 31, 2025 ↗ |
| GESTION BOUTIQUE IV, FI GESTION BOUTIQUE IV/ONLY COMPOUNDERS ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 2.63 % | as of Dec 31, 2025 ↗ |
| Pictet - Health Pictet Asset Management (Europe) S.A. | 2.63 % | as of Sep 30, 2025 ↗ |
| Comgest Growth Europe ex UK Comgest Asset Management International Limited | 2.55 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 197 | -9 | 4,204,300 | -15.7 % |
| 2026Q1 | 206 | -4 | 4,985,430 | +2.6 % |
| 2025Q4 | 210 | +5 | 4,861,199 | +12.0 % |
| 2025Q3 | 205 | +15 | 4,340,509 | -4.3 % |
| 2025Q2 | 190 | +2 | 4,537,208 | +21.1 % |
| 2025Q1 | 188 | -16 | 3,746,613 | -16.3 % |
| 2024Q4 | 204 | -24 | 4,477,229 | -16.1 % |
| 2024Q3 | 228 | -16 | 5,337,869 | +3.9 % |
| 2024Q2 | 244 | +21 | 5,136,357 | +38.7 % |
| 2024Q1 | 223 | -21 | 3,703,899 | -16.9 % |
| 2023Q4 | 244 | 4,454,554 |
Short sellers of Sartorius Stedim Biotech
Regulators publish the open short positions in this company. Titelia read them from quivad on Aug 20, 2026: today's figure
This market only publishes an aggregate total, naming no seller. It stood at 1.7 % as of Aug 6, 2026.
Cite this page
Titelia. "Fund shareholders of Sartorius Stedim Biotech". https://titelia.com/en/stocks/sartorius-stedim-biotech-FR0013154002